9-34179081-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_016525.5(UBAP1):c.-167G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,278,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000023 ( 0 hom. )
Consequence
UBAP1
NM_016525.5 5_prime_UTR_premature_start_codon_gain
NM_016525.5 5_prime_UTR_premature_start_codon_gain
Scores
1
1
12
Clinical Significance
Conservation
PhyloP100: 0.0930
Genes affected
UBAP1 (HGNC:12461): (ubiquitin associated protein 1) This gene is a member of the UBA domain family, whose members include proteins having connections to ubiquitin and the ubiquitination pathway. The ubiquitin associated domain is thought to be a non-covalent ubiquitin binding domain consisting of a compact three helix bundle. This particular protein originates from a gene locus in a refined region on chromosome 9 undergoing loss of heterozygosity in nasopharyngeal carcinoma (NPC). Taking into account its cytogenetic location, this UBA domain family member is being studies as a putative target for mutation in nasopharyngeal carcinomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13189098).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0000788 (12/152254) while in subpopulation AFR AF= 0.000217 (9/41558). AF 95% confidence interval is 0.000112. There are 0 homozygotes in gnomad4. There are 6 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 12 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBAP1 | NM_016525.5 | c.-167G>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/7 | ENST00000297661.9 | NP_057609.2 | ||
UBAP1 | NM_016525.5 | c.-167G>T | 5_prime_UTR_variant | 1/7 | ENST00000297661.9 | NP_057609.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBAP1 | ENST00000297661 | c.-167G>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/7 | 1 | NM_016525.5 | ENSP00000297661.4 | |||
UBAP1 | ENST00000297661 | c.-167G>T | 5_prime_UTR_variant | 1/7 | 1 | NM_016525.5 | ENSP00000297661.4 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152136Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
12
AN:
152136
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000231 AC: 26AN: 1125748Hom.: 0 Cov.: 33 AF XY: 0.0000148 AC XY: 8AN XY: 540338
GnomAD4 exome
AF:
AC:
26
AN:
1125748
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
540338
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152254Hom.: 0 Cov.: 31 AF XY: 0.0000806 AC XY: 6AN XY: 74450
GnomAD4 genome
AF:
AC:
12
AN:
152254
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.67G>T (p.G23C) alteration is located in exon 1 (coding exon 1) of the UBAP1 gene. This alteration results from a G to T substitution at nucleotide position 67, causing the glycine (G) at amino acid position 23 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
Sift4G
Pathogenic
D;D
Vest4
MVP
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at